Gene · 9261
Papers3,346
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
641 to 660 of 3,346
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Efficacy of the Synergy Between Live-Attenuated and Inactivated PRRSV Vaccines Against a NADC30-Like Strain of Porcine Reproductive and Respiratory Syndrome Virus in 4-Week Piglets. | Front Vet Sci | 2022 | 35187144 | PubTator, text mining | PubMed |
| Effects of transforming growth factor beta-activated kinase 1 (TAK1) on apoptosis of HK-2 cells in the high glucose environment. | Bioengineered | 2022 | 35184673 | PubTator, text mining | PubMed |
| Adverse Effects of Vemurafenib on Skin Integrity: Hyperkeratosis and Skin Cancer Initiation Due to Altered MEK/ERK-Signaling and MMP Activity. | Front Oncol | 2022 | 35174094 | PubTator, text mining | PubMed |
| Nanomedicine Strategies for Management of Drug Resistance in Lung Cancer. | Int J Mol Sci | 2022 | 35163777 | PubTator, text mining | PubMed |
| Functional Roles of JNK and p38 MAPK Signaling in Nasopharyngeal Carcinoma. | Int J Mol Sci | 2022 | 35163030 | PubTator, text mining | PubMed |
| Dissection of the MKK3 Functions in Human Cancer: A Double-Edged Sword? | Cancers (Basel) | 2022 | 35158751 | PubTator, text mining | PubMed |
| Long non-coding RNAs as the critical regulators of epithelial mesenchymal transition in colorectal tumor cells: an overview. | Cancer Cell Int | 2022 | 35144601 | PubTator, text mining | PubMed |
| Senescence and the tumor-immune landscape: Implications for cancer immunotherapy. | Semin Cancer Biol | 2022 | 35143990 | PubTator, text mining | PubMed |
| Genomic legacy of migration in endangered caribou. | PLoS Genet | 2022 | 35143486 | PubTator, text mining | PubMed |
| 14-3-3 Proteins are Potential Regulators of Liquid-Liquid Phase Separation. | Cell Biochem Biophys | 2022 | 35142991 | PubTator, text mining | PubMed |
| Plasma miRNA profile at COVID-19 onset predicts severity status and mortality. | Emerg Microbes Infect | 2022 | 35130828 | PubTator, text mining | PubMed |
| Regulation of CCR4-NOT complex deadenylase activity and cellular responses by MK2-dependent phosphorylation of CNOT2. | RNA Biol | 2022 | 35129087 | PubTator, text mining | PubMed |
| Therapeutic Targets of Bufalin on Renal Carcinoma and Mechanisms: Experimental Validation of Network Pharmacology Analysis. | Evid Based Complement Alternat Med | 2022 | 35126601 | PubTator, text mining | PubMed |
| Decisive role of water and protein dynamics in residence time of p38α MAP kinase inhibitors. | Nat Commun | 2022 | 35091547 | PubTator, text mining | PubMed |
| Overcoming barriers for intra-articular delivery of disease-modifying osteoarthritis drugs. | Trends Pharmacol Sci | 2022 | 35086691 | PubTator, text mining | PubMed |
| Kinase signaling as a drug target modality for regulation of vascular hyperpermeability: A case for ARDS therapy development. | Drug Discov Today | 2022 | 35085784 | PubTator, text mining | PubMed |
| Research Progress in the Pharmacological Activities, Toxicities, and Pharmacokinetics of Sophoridine and Its Derivatives. | Drug Des Devel Ther | 2022 | 35082485 | PubTator, text mining | PubMed |
| Combination therapy targeting Erk1/2 and CDK4/6i in relapsed refractory multiple myeloma. | Leukemia | 2022 | 35082402 | PubTator, text mining | PubMed |
| A non-catalytic herpesviral protein reconfigures ERK-RSK signaling by targeting kinase docking systems in the host. | Nat Commun | 2022 | 35078976 | PubTator, text mining | PubMed |
| TLK1-mediated MK5-S354 phosphorylation drives prostate cancer cell motility and may signify distinct pathologies. | Mol Oncol | 2022 | 35064619 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/9261/papers?page=33